aluates Reports

$ 0.0

Automative

Global Vaccinia Virus (VACV) Service Market Research Report 2026

Published Date: 2026-01-20

Report Code: QYRE-Auto-20U18904

Global Vaccinia Virus VACV Service Market Research Report 2024

BUY CHAPTERS

Global Vaccinia Virus (VACV) Service Market Research Report 2026

Code: QYRE-Auto-20U18904

Report

2026-01-20

Pages:110

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

VectorBuilder

Creative-Biolabs

Creative Biogene

Esco Aster Pte. Ltd

Sementis

Genevoyager (Wuhan) Co., Ltd.

Vaccinia Virus (VACV) Service Market Size

The global Vaccinia Virus (VACV) Service market was valued at US$ 95.31 million in 2025 and is anticipated to reach US$ 181 million by 2032, at a CAGR of 9.7% from 2026 to 2032.

Vaccinia Virus (VACV) Service Market

Vaccinia virus (VACV or VV) is the most widely used viral vector for the study of exogenous gene expression and immunogenicity of the resulting protein. Replication-competent recombinant VACV-based vaccines have received increasing attention as potential vaccine vectors for many infectious diseases, as they may be able to elicit potent humoral and cell-mediated immune responses and long-lasting protection.Vaccinia virus (VACV) is a large enveloped, double-stranded DNA virus in the genus of Orthopoxvirus of the family Poxviridae. The VACV genome is comprised of approximately 190,000 nucleotides which encodes approximately 250 genes. VACV is one of the most commonly developed oncolytic vectors. There are several features make VACV a promising oncolytic vector which include excellent lytic activity, natural and broad tumor tropism as well as well-known and easy-manipulating genome structure etc.

The North American market for Vaccinia Virus (VACV) Service is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

The Asia-Pacific market for Vaccinia Virus (VACV) Service is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

The global market for Vaccinia Virus (VACV) Service in Scientific Research is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.

Major global companies of Vaccinia Virus (VACV) Service include VectorBuilder, Creative Biolabs, Creative Biogene, Genevoyager (Wuhan) Co., Ltd., Esco Aster Pte. Ltd., Sementis, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.

This report delivers a comprehensive overview of the global Vaccinia Virus (VACV) Service market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Vaccinia Virus (VACV) Service. The Vaccinia Virus (VACV) Service market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Vaccinia Virus (VACV) Service market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Vaccinia Virus (VACV) Service manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Vaccinia Virus (VACV) Service Market Report

Report Metric	Details
Report Name	Vaccinia Virus (VACV) Service Market
Accounted market size in 2025	US$ 95.31 million
Forecasted market size in 2032	US$ 181 million
CAGR	9.7%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	Attenuated Vaccinia Virus Recombinant Vaccinia Virus Other
Segment by Application	Scientific Research Vaccine Development Oncolytic Therapy
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	VectorBuilder, Creative Biolabs, Creative Biogene, Genevoyager (Wuhan) Co., Ltd., Esco Aster Pte. Ltd., Sementis
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Vaccinia Virus (VACV) Service companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is Vaccinia Virus (VACV) Service Market growing?

Ans: The Vaccinia Virus (VACV) Service Market witnessing a CAGR of 9.7% during the forecast period 2026-2032.

What is the Vaccinia Virus (VACV) Service Market size in 2032?

Ans: The Vaccinia Virus (VACV) Service Market size in 2032 will be US$ 181 million.

Who are the main players in the Vaccinia Virus (VACV) Service Market report?

Ans: The main players in the Vaccinia Virus (VACV) Service Market are VectorBuilder, Creative Biolabs, Creative Biogene, Genevoyager (Wuhan) Co., Ltd., Esco Aster Pte. Ltd., Sementis

What are the Application segmentation covered in the Vaccinia Virus (VACV) Service Market report?

Ans: The Applications covered in the Vaccinia Virus (VACV) Service Market report are Scientific Research, Vaccine Development, Oncolytic Therapy

What are the Type segmentation covered in the Vaccinia Virus (VACV) Service Market report?

Ans: The Types covered in the Vaccinia Virus (VACV) Service Market report are Attenuated Vaccinia Virus, Recombinant Vaccinia Virus, Other

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Vaccinia Virus (VACV) Service Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 Attenuated Vaccinia Virus

1.2.3 Recombinant Vaccinia Virus

1.2.4 Other

1.3 Market by Application

1.3.1 Global Vaccinia Virus (VACV) Service Market Growth by Application: 2021 vs 2025 vs 2032

1.3.2 Scientific Research

1.3.3 Vaccine Development

1.3.4 Oncolytic Therapy

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Vaccinia Virus (VACV) Service Market Perspective (2021–2032)

2.2 Global Vaccinia Virus (VACV) Service Growth Trends by Region

2.2.1 Global Vaccinia Virus (VACV) Service Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 Vaccinia Virus (VACV) Service Historic Market Size by Region (2021–2026)

2.2.3 Vaccinia Virus (VACV) Service Forecasted Market Size by Region (2027–2032)

2.3 Vaccinia Virus (VACV) Service Market Dynamics

2.3.1 Vaccinia Virus (VACV) Service Industry Trends

2.3.2 Vaccinia Virus (VACV) Service Market Drivers

2.3.3 Vaccinia Virus (VACV) Service Market Challenges

2.3.4 Vaccinia Virus (VACV) Service Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Vaccinia Virus (VACV) Service Players by Revenue

3.1.1 Global Top Vaccinia Virus (VACV) Service Players by Revenue (2021–2026)

3.1.2 Global Vaccinia Virus (VACV) Service Revenue Market Share by Players (2021–2026)

3.2 Global Top Vaccinia Virus (VACV) Service Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by Vaccinia Virus (VACV) Service Revenue

3.4 Global Vaccinia Virus (VACV) Service Market Concentration Ratio

3.4.1 Global Vaccinia Virus (VACV) Service Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Vaccinia Virus (VACV) Service Revenue in 2025

3.5 Global Key Players of Vaccinia Virus (VACV) Service Head Offices and Areas Served

3.6 Global Key Players of Vaccinia Virus (VACV) Service, Products and Applications

3.7 Global Key Players of Vaccinia Virus (VACV) Service, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 Vaccinia Virus (VACV) Service Breakdown Data by Type

4.1 Global Vaccinia Virus (VACV) Service Historic Market Size by Type (2021–2026)

4.2 Global Vaccinia Virus (VACV) Service Forecasted Market Size by Type (2027–2032)

5 Vaccinia Virus (VACV) Service Breakdown Data by Application

5.1 Global Vaccinia Virus (VACV) Service Historic Market Size by Application (2021–2026)

5.2 Global Vaccinia Virus (VACV) Service Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America Vaccinia Virus (VACV) Service Market Size (2021–2032)

6.2 North America Vaccinia Virus (VACV) Service Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America Vaccinia Virus (VACV) Service Market Size by Country (2021–2026)

6.4 North America Vaccinia Virus (VACV) Service Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Vaccinia Virus (VACV) Service Market Size (2021–2032)

7.2 Europe Vaccinia Virus (VACV) Service Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe Vaccinia Virus (VACV) Service Market Size by Country (2021–2026)

7.4 Europe Vaccinia Virus (VACV) Service Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Vaccinia Virus (VACV) Service Market Size (2021–2032)

8.2 Asia-Pacific Vaccinia Virus (VACV) Service Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific Vaccinia Virus (VACV) Service Market Size by Region (2021–2026)

8.4 Asia-Pacific Vaccinia Virus (VACV) Service Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Vaccinia Virus (VACV) Service Market Size (2021–2032)

9.2 Latin America Vaccinia Virus (VACV) Service Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America Vaccinia Virus (VACV) Service Market Size by Country (2021–2026)

9.4 Latin America Vaccinia Virus (VACV) Service Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Vaccinia Virus (VACV) Service Market Size (2021–2032)

10.2 Middle East & Africa Vaccinia Virus (VACV) Service Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa Vaccinia Virus (VACV) Service Market Size by Country (2021–2026)

10.4 Middle East & Africa Vaccinia Virus (VACV) Service Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 VectorBuilder

11.1.1 VectorBuilder Company Details

11.1.2 VectorBuilder Business Overview

11.1.3 VectorBuilder Vaccinia Virus (VACV) Service Introduction

11.1.4 VectorBuilder Revenue in Vaccinia Virus (VACV) Service Business (2021–2026)

11.1.5 VectorBuilder Recent Development

11.2 Creative Biolabs

11.2.1 Creative Biolabs Company Details

11.2.2 Creative Biolabs Business Overview

11.2.3 Creative Biolabs Vaccinia Virus (VACV) Service Introduction

11.2.4 Creative Biolabs Revenue in Vaccinia Virus (VACV) Service Business (2021–2026)

11.2.5 Creative Biolabs Recent Development

11.3 Creative Biogene

11.3.1 Creative Biogene Company Details

11.3.2 Creative Biogene Business Overview

11.3.3 Creative Biogene Vaccinia Virus (VACV) Service Introduction

11.3.4 Creative Biogene Revenue in Vaccinia Virus (VACV) Service Business (2021–2026)

11.3.5 Creative Biogene Recent Development

11.4 Genevoyager (Wuhan) Co., Ltd.

11.4.1 Genevoyager (Wuhan) Co., Ltd. Company Details

11.4.2 Genevoyager (Wuhan) Co., Ltd. Business Overview

11.4.3 Genevoyager (Wuhan) Co., Ltd. Vaccinia Virus (VACV) Service Introduction

11.4.4 Genevoyager (Wuhan) Co., Ltd. Revenue in Vaccinia Virus (VACV) Service Business (2021–2026)

11.4.5 Genevoyager (Wuhan) Co., Ltd. Recent Development

11.5 Esco Aster Pte. Ltd.

11.5.1 Esco Aster Pte. Ltd. Company Details

11.5.2 Esco Aster Pte. Ltd. Business Overview

11.5.3 Esco Aster Pte. Ltd. Vaccinia Virus (VACV) Service Introduction

11.5.4 Esco Aster Pte. Ltd. Revenue in Vaccinia Virus (VACV) Service Business (2021–2026)

11.5.5 Esco Aster Pte. Ltd. Recent Development

11.6 Sementis

11.6.1 Sementis Company Details

11.6.2 Sementis Business Overview

11.6.3 Sementis Vaccinia Virus (VACV) Service Introduction

11.6.4 Sementis Revenue in Vaccinia Virus (VACV) Service Business (2021–2026)

11.6.5 Sementis Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

VectorBuilder

Creative-Biolabs

Creative Biogene

Esco Aster Pte. Ltd

Sementis

Genevoyager (Wuhan) Co., Ltd.

List of Tables

Table 1. Global Vaccinia Virus (VACV) Service Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of Attenuated Vaccinia Virus

Table 3. Key Players of Recombinant Vaccinia Virus

Table 4. Key Players of Other

Table 5. Global Vaccinia Virus (VACV) Service Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 6. Global Vaccinia Virus (VACV) Service Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 7. Global Vaccinia Virus (VACV) Service Market Size by Region (US$ Million), 2021–2026

Table 8. Global Vaccinia Virus (VACV) Service Market Share by Region (2021–2026)

Table 9. Global Vaccinia Virus (VACV) Service Forecasted Market Size by Region (US$ Million), 2027–2032

Table 10. Global Vaccinia Virus (VACV) Service Market Share by Region (2027–2032)

Table 11. Vaccinia Virus (VACV) Service Market Trends

Table 12. Vaccinia Virus (VACV) Service Market Drivers

Table 13. Vaccinia Virus (VACV) Service Market Challenges

Table 14. Vaccinia Virus (VACV) Service Market Restraints

Table 15. Global Vaccinia Virus (VACV) Service Revenue by Players (US$ Million), 2021–2026

Table 16. Global Vaccinia Virus (VACV) Service Market Share by Players (2021–2026)

Table 17. Global Top Vaccinia Virus (VACV) Service Players by Tier (Tier 1, Tier 2, and Tier 3), based on Vaccinia Virus (VACV) Service Revenue, 2025

Table 18. Ranking of Global Top Vaccinia Virus (VACV) Service Companies by Revenue (US$ Million) in 2025

Table 19. Global 5 Largest Players Market Share by Vaccinia Virus (VACV) Service Revenue (CR5 and HHI), 2021–2026

Table 20. Global Key Players of Vaccinia Virus (VACV) Service, Headquarters and Area Served

Table 21. Global Key Players of Vaccinia Virus (VACV) Service, Products and Applications

Table 22. Global Key Players of Vaccinia Virus (VACV) Service, Date of General Availability (GA)

Table 23. Mergers and Acquisitions, Expansion Plans

Table 24. Global Vaccinia Virus (VACV) Service Market Size by Type (US$ Million), 2021–2026

Table 25. Global Vaccinia Virus (VACV) Service Revenue Market Share by Type (2021–2026)

Table 26. Global Vaccinia Virus (VACV) Service Forecasted Market Size by Type (US$ Million), 2027–2032

Table 27. Global Vaccinia Virus (VACV) Service Revenue Market Share by Type (2027–2032)

Table 28. Global Vaccinia Virus (VACV) Service Market Size by Application (US$ Million), 2021–2026

Table 29. Global Vaccinia Virus (VACV) Service Revenue Market Share by Application (2021–2026)

Table 30. Global Vaccinia Virus (VACV) Service Forecasted Market Size by Application (US$ Million), 2027–2032

Table 31. Global Vaccinia Virus (VACV) Service Revenue Market Share by Application (2027–2032)

Table 32. North America Vaccinia Virus (VACV) Service Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 33. North America Vaccinia Virus (VACV) Service Market Size by Country (US$ Million), 2021–2026

Table 34. North America Vaccinia Virus (VACV) Service Market Size by Country (US$ Million), 2027–2032

Table 35. Europe Vaccinia Virus (VACV) Service Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 36. Europe Vaccinia Virus (VACV) Service Market Size by Country (US$ Million), 2021–2026

Table 37. Europe Vaccinia Virus (VACV) Service Market Size by Country (US$ Million), 2027–2032

Table 38. Asia-Pacific Vaccinia Virus (VACV) Service Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 39. Asia-Pacific Vaccinia Virus (VACV) Service Market Size by Region (US$ Million), 2021–2026

Table 40. Asia-Pacific Vaccinia Virus (VACV) Service Market Size by Region (US$ Million), 2027–2032

Table 41. Latin America Vaccinia Virus (VACV) Service Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 42. Latin America Vaccinia Virus (VACV) Service Market Size by Country (US$ Million), 2021–2026

Table 43. Latin America Vaccinia Virus (VACV) Service Market Size by Country (US$ Million), 2027–2032

Table 44. Middle East & Africa Vaccinia Virus (VACV) Service Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 45. Middle East & Africa Vaccinia Virus (VACV) Service Market Size by Country (US$ Million), 2021–2026

Table 46. Middle East & Africa Vaccinia Virus (VACV) Service Market Size by Country (US$ Million), 2027–2032

Table 47. VectorBuilder Company Details

Table 48. VectorBuilder Business Overview

Table 49. VectorBuilder Vaccinia Virus (VACV) Service Product

Table 50. VectorBuilder Revenue in Vaccinia Virus (VACV) Service Business (US$ Million), 2021–2026

Table 51. VectorBuilder Recent Development

Table 52. Creative Biolabs Company Details

Table 53. Creative Biolabs Business Overview

Table 54. Creative Biolabs Vaccinia Virus (VACV) Service Product

Table 55. Creative Biolabs Revenue in Vaccinia Virus (VACV) Service Business (US$ Million), 2021–2026

Table 56. Creative Biolabs Recent Development

Table 57. Creative Biogene Company Details

Table 58. Creative Biogene Business Overview

Table 59. Creative Biogene Vaccinia Virus (VACV) Service Product

Table 60. Creative Biogene Revenue in Vaccinia Virus (VACV) Service Business (US$ Million), 2021–2026

Table 61. Creative Biogene Recent Development

Table 62. Genevoyager (Wuhan) Co., Ltd. Company Details

Table 63. Genevoyager (Wuhan) Co., Ltd. Business Overview

Table 64. Genevoyager (Wuhan) Co., Ltd. Vaccinia Virus (VACV) Service Product

Table 65. Genevoyager (Wuhan) Co., Ltd. Revenue in Vaccinia Virus (VACV) Service Business (US$ Million), 2021–2026

Table 66. Genevoyager (Wuhan) Co., Ltd. Recent Development

Table 67. Esco Aster Pte. Ltd. Company Details

Table 68. Esco Aster Pte. Ltd. Business Overview

Table 69. Esco Aster Pte. Ltd. Vaccinia Virus (VACV) Service Product

Table 70. Esco Aster Pte. Ltd. Revenue in Vaccinia Virus (VACV) Service Business (US$ Million), 2021–2026

Table 71. Esco Aster Pte. Ltd. Recent Development

Table 72. Sementis Company Details

Table 73. Sementis Business Overview

Table 74. Sementis Vaccinia Virus (VACV) Service Product

Table 75. Sementis Revenue in Vaccinia Virus (VACV) Service Business (US$ Million), 2021–2026

Table 76. Sementis Recent Development

Table 77. Research Programs/Design for This Report

Table 78. Key Data Information from Secondary Sources

Table 79. Key Data Information from Primary Sources

Table 80. Authors List of This Report

List of Figures

Figure 1. Vaccinia Virus (VACV) Service Picture

Figure 2. Global Vaccinia Virus (VACV) Service Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global Vaccinia Virus (VACV) Service Market Share by Type: 2025 vs 2032

Figure 4. Attenuated Vaccinia Virus Features

Figure 5. Recombinant Vaccinia Virus Features

Figure 6. Other Features

Figure 7. Global Vaccinia Virus (VACV) Service Market Size by Application (US$ Million), 2021–2032

Figure 8. Global Vaccinia Virus (VACV) Service Market Share by Application: 2025 vs 2032

Figure 9. Scientific Research Case Studies

Figure 10. Vaccine Development Case Studies

Figure 11. Oncolytic Therapy Case Studies

Figure 12. Vaccinia Virus (VACV) Service Report Years Considered

Figure 13. Global Vaccinia Virus (VACV) Service Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 14. Global Vaccinia Virus (VACV) Service Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 15. Global Vaccinia Virus (VACV) Service Market Share by Region: 2025 vs 2032

Figure 16. Global Vaccinia Virus (VACV) Service Market Share by Players in 2025

Figure 17. Global Vaccinia Virus (VACV) Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 18. The Top 10 and 5 Players Market Share by Vaccinia Virus (VACV) Service Revenue in 2025

Figure 19. North America Vaccinia Virus (VACV) Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 20. North America Vaccinia Virus (VACV) Service Market Share by Country (2021–2032)

Figure 21. United States Vaccinia Virus (VACV) Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 22. Canada Vaccinia Virus (VACV) Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 23. Europe Vaccinia Virus (VACV) Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 24. Europe Vaccinia Virus (VACV) Service Market Share by Country (2021–2032)

Figure 25. Germany Vaccinia Virus (VACV) Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 26. France Vaccinia Virus (VACV) Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 27. U.K. Vaccinia Virus (VACV) Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 28. Italy Vaccinia Virus (VACV) Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 29. Russia Vaccinia Virus (VACV) Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 30. Ireland Vaccinia Virus (VACV) Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 31. Asia-Pacific Vaccinia Virus (VACV) Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 32. Asia-Pacific Vaccinia Virus (VACV) Service Market Share by Region (2021–2032)

Figure 33. China Vaccinia Virus (VACV) Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 34. Japan Vaccinia Virus (VACV) Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 35. South Korea Vaccinia Virus (VACV) Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 36. Southeast Asia Vaccinia Virus (VACV) Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 37. India Vaccinia Virus (VACV) Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 38. Australia & New Zealand Vaccinia Virus (VACV) Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 39. Latin America Vaccinia Virus (VACV) Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 40. Latin America Vaccinia Virus (VACV) Service Market Share by Country (2021–2032)

Figure 41. Mexico Vaccinia Virus (VACV) Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 42. Brazil Vaccinia Virus (VACV) Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 43. Middle East & Africa Vaccinia Virus (VACV) Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 44. Middle East & Africa Vaccinia Virus (VACV) Service Market Share by Country (2021–2032)

Figure 45. Israel Vaccinia Virus (VACV) Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 46. Saudi Arabia Vaccinia Virus (VACV) Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 47. UAE Vaccinia Virus (VACV) Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 48. VectorBuilder Revenue Growth Rate in Vaccinia Virus (VACV) Service Business (2021–2026)

Figure 49. Creative Biolabs Revenue Growth Rate in Vaccinia Virus (VACV) Service Business (2021–2026)

Figure 50. Creative Biogene Revenue Growth Rate in Vaccinia Virus (VACV) Service Business (2021–2026)

Figure 51. Genevoyager (Wuhan) Co., Ltd. Revenue Growth Rate in Vaccinia Virus (VACV) Service Business (2021–2026)

Figure 52. Esco Aster Pte. Ltd. Revenue Growth Rate in Vaccinia Virus (VACV) Service Business (2021–2026)

Figure 53. Sementis Revenue Growth Rate in Vaccinia Virus (VACV) Service Business (2021–2026)

Figure 54. Bottom-up and Top-down Approaches for This Report

Figure 55. Data Triangulation

Figure 56. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Recombinant Vector Vaccines Market Insights Forecast to 2030

Global Adenovirus Services Market Research Report 2025

Chickenpox Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Oncolytic Virus Market Insights Forecast to 2030

Global Smallpox Vaccine Market Research Report 2024

Adenovirus Vector Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Oncolytic Virus Therapy Market Research Report 2025

Global Viral Vectors Gene Therapy Market Research Report 2025

Global Avian Pox Vaccine Market Research Report 2024

Recombinant DNA Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Monkeypox Vaccine Market Research Report 2025

Global Oncolytic Virus Cancer Immunotherapy Market Insights Forecast to 2030

Global Oncolytic Virus Immunotherapy Market Research Report 2024

Global Viral Vector Purification Market Research Report 2025

Global DNA Vaccines Market Insights Forecast to 2030

Viral Vector Production Research use Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Viral Vector and Plasmid DNA Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Gene Therapy Sales Market Report Competitive Analysis and Regional Opportunities 2025 2031

Viral Vector and Plasmid DNA Testing Service Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions